Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.

Authors:
Sun CY; Yang LL; Zhao P; Yan PZ; Li J and 1 more

Journal:
Hereditas

Publication Year: 2022

DOI:
10.1186/s41065-022-00256-7

PMCID:
PMC9714250

PMID:
36451177

Journal Information

Full Title: Hereditas

Abbreviation: Hereditas

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors have declared no potential financial conflicts of interest. Competing interests The authors have declared no potential financial conflicts of interest."

Evidence found in paper:

"Funding The national key research and development program of China (2017YFC1701500), the national natural science foundation of China (81903780, 82004233, and 81872963), a project funded by the traditional Chinese medicine science and technology development plan of Shandong province (2019-0030)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025